Amia Capital LLP Halozyme Therapeutics, Inc. Transaction History

Amia Capital LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$25.81 - $43.62 $936,360 - $1.58 Million	-36,279 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$25.74 - $29.63 $248,519 - $286,077	-9,655 Reduced 21.02%	36,279 $953,000
Q2 2020 Aug 14, 2020	SELL	$16.25 - $26.81 $381,468 - $629,364	-23,475 Reduced 33.82%	45,934 $1.23 Million
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $280,279 - $440,180	-20,164 Reduced 22.51%	69,409 $1.25 Million
Q4 2019 Feb 13, 2020	BUY	$14.93 - $19.53 $1.34 Million - $1.75 Million	89,573 New	89,573 $1.59 Million

450

123M

216K

129K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.53B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.